Home » Topics » BioWorld Science

BioWorld Science
RSS

FDA grants RMAT designation to ABO-102 for MPS IIIA

April 25, 2018

Shire willing to recommend Takeda's revised proposal to shareholders

April 25, 2018

Researchers present novel IDO-1 inhibitor for cancer

April 25, 2018

FDA approves Jynarque to slow kidney function decline in adults with ADPKD

April 25, 2018

Takeda set to begin voluntary and conditional public takeover bid for TiGenix

April 25, 2018

Curadev Pharma targets ACSS2 for antitumor agents

April 25, 2018

Boehringer Ingelheim and Topas Therapeutics enter research agreement

April 25, 2018

First patient enrolled in phase III trial of topical ocular reproxalap

April 25, 2018

Results on sodium oxybate presented in pediatric patients with narcolepsy type 1

April 25, 2018

Third Rock Ventures launches Cedilla Therapeutics

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...